Parambil
PrivateLast Round
Seed
Jan 14, 2026
Total Funding Raised
$8.12M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Parambil operates in AI, Data & Cloud Infrastructure and is based in New York City, New York. Its latest recorded funding round was a Seed round in January 2026.
Parambil is a legal technology company that provides an AI-powered knowledge platform for tort law, offering tools for medical record review, case validation, and litigation support.
Sector
AI, Data & Cloud Infrastructure
Verticals
Legal Tech, Medical AI, Workflow Automation, Document Management, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parambil Comparables
Compare Parambil with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turbo Law | 85% | |
| Paxton AI | 84% | |
| Briefpoint | 80% |
For institutional investors. Book with your work email.
Parambil Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 14, 2026 | ||||
| Pre Seed | Jan 15, 2025 | ||||
| Accelerator | Feb 13, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Parambil Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| nvp capital | Seed |
| Techstars | Pre Seed, Accelerator |
| Daybreak Capital | Seed |
| Daybreak Ventures | Pre Seed |
| Bling Capital | Seed |
| Newark Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Grew 27% QoQ, from 15 to 19 employees.
- Aug 21, 2026
Monthly visitors grew 136% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientOct 1, 2026
CM Injury selected Parambil as its AI medical record review platform for complex medical litigation in New York on Oct 1st '26.
For institutional investors. Book with your work email.
Parambil Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Parambil's valuation, stock price, and market status.
Is Parambil a public or private company?
Parambil is a private company.
What is the current stock price of Parambil?
Parambil is a private company, so its shares have no public market price. Caplight tracks Parambil's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Parambil worth (valuation)?
Valuation information for Parambil is not publicly available.
Can I buy Parambil stock?
Parambil shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Parambil's last funding round?
Parambil's most recent funding round was Seed on January 14, 2026.
Who are the main investors in Parambil?
Key investors in Parambil include Daybreak Ventures, Bling Capital.
Will Parambil IPO soon?
No public IPO plans have been announced for Parambil.
How can I track Parambil secondary market activity?
Caplight tracks bids, offers, and trades in Parambil's shares on secondary markets.